SCAD REGULATES CARDIOMYOCYTE APOPTOSIS THROUGH AMPK/PPARA/SCAD SIGNALLING PATHWAY

Jiawang Wang,Zesheng Xu,Qiong Wu,Nan Guo,Jing Yu,Xufen Cao
DOI: https://doi.org/10.19193/0393-6384_2020_1_11
2020-01-01
Acta medica mediterranea
Abstract:Objective: To analyse the effect of short-chain acyl coenzyme A dehydrogenase (SCAD) on cardiomyocyte apoptosis and its possible regulation mechanism. Methods: T-butyl hydroperoxide (tBHP) was applied to cardiomyocytes, and a cardiomvocyte apoptosis model was established to detect changes in SCAD protein levels and cell viability in cardiomyocytes. Then siRNA-1186 was used to interfere with SCAD expression, and the change of SCAD protein level, cell survival rate and apoptotic rate after interference myocardial cells were detected. The change of CAD and PPAR alpha protein levels were determined by using PPAR alpha agonist fenofbrate (Feno)for 30 min after treatment of cardiomyocyres. After pretreatment of cardiomyocytes with AMPK agonist AICAR for 30 min, tBHP was applied to cardiomyocytes to detect changes in SCAD, PPAR alpha and phosphorylated adenylate-activated protein kinase alpha (p-AMPK alpha) protein expression levels. Results: MMT colorimetry showed that the survival rate of cardiomyocytes decreased with increased concentrations of tBHP and longer times. The cell survival rate was 50% when the concentration of tBHP was 200 mu mol/L at 6 hours. Western blotting showed that the expression of SCAD protein decreased significantly at 6 hours and the concentration of tBHP was 200 mu mol/L (P<0.05). After siRNA-1186 was applied to cardiomyocyres, the expression of SCAD protein and the cell survival rate decreased significantly, while the apoptotic rate was significantly higher, which was consistent with the trend of apoptosis induced by tBHP. The expression levels of SCAD and PPAR alpha protein in Feno+tBHP group were significantly higher than those in tBHP group (P<0.05). The expression level of SCAD, PPAR alpha, and p-AMPK alpha protein in AICAR+tBHP group was significantly higher than that of tBHP group (P<0.05). Conclusion: Up-regulation of SCAD expression may reduce the apoptosis rate of cardiomyocytes, and its mechanism may be related to the regulation of AMPK/PPAR alpha/SCAD signalling pathway by SCAD. SCAD can be a new target to treat heart failure diseases.
What problem does this paper attempt to address?